AlphaCentric Advisors »

Moonlake Immunot shares owned by AlphaCentric Advisors

Quarter-by-quarter ownership of Moonlake Immunot (MLTX) shares owned by AlphaCentric Advisors from 13F filings

Historical chart of AlphaCentric Advisors investment in Moonlake Immunot

Tip: Access up to 7 years of quarterly data

All positions including Moonlake Immunot held by AlphaCentric Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Moonlake Immunot by AlphaCentric Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $706k 14k 50.42

More positions owned by AlphaCentric Advisors

Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Johnson & Johnson (JNJ)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Abbvie (ABBV)
Merck & Co (MRK)
Thermo Fisher Scientific (TMO)
Astrazeneca Sponsored Adr (AZN)
Novo-nordisk A S Adr (NVO)
Globus Med Cl A (GMED)
Invesco Exchange Traded Fd T S&p500 Pur Val (RPV)
Ishares Tr Rus 1000 Val Etf (IWD)
Intuitive Surgical Com New (ISRG)
Lamar Advertising Cl A (LAMR)
Boston Scientific Corporation (BSX)

View all positions for AlphaCentric Advisors

Top funds holding Moonlake Immunot

BVF
Cormorant Asset Management
FMR
T. Rowe Price Associates
venBio Select Advisor
Citadel Advisors
Goldman Sachs Group
Holocene Advisors
Westfield Capital Management Company
Federated Investors
Marshall Wace
Alliancebernstein
Paradigm Biocapital Advisors
Fred Alger Management
Hood River Capital Management

View all funds holding Moonlake Immunot